Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination
L di Filippo, S Frara, U Terenzi, F Nannipieri… - Endocrine, 2023 - Springer
Purpose Low vitamin D levels were reported to negatively influence the outcome of acute
COVID-19, as well as to be linked to Long-COVID. However, few studies have investigated …
COVID-19, as well as to be linked to Long-COVID. However, few studies have investigated …
Antibody responses after SARS-CoV-2 vaccination in patients with liver diseases
AD Bakasis, K Bitzogli, D Mouziouras, A Pouliakis… - Viruses, 2022 - mdpi.com
The novel mRNA-based vaccines against SARS-CoV-2 display encouraging safety and
efficacy profiles. However, there is a paucity of data regarding their immunogenicity and …
efficacy profiles. However, there is a paucity of data regarding their immunogenicity and …
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies
Understanding the decay and maintenance of long-term SARS-CoV-2 neutralizing
antibodies in infected or vaccinated people and how vaccines protect against other SARS …
antibodies in infected or vaccinated people and how vaccines protect against other SARS …
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia
SL Yang, A Mat Ripen, CT Leong, JV Lee… - Emerging Microbes & …, 2022 - Taylor & Francis
The evaluation of breakthrough infection and humoral immunity responses are important
outcomes for vaccination policy for healthcare staff. This prospective cohort study collected …
outcomes for vaccination policy for healthcare staff. This prospective cohort study collected …
SARS-CoV-2 breakthrough infections according to the immune response elicited after mRNA third dose vaccination in COVID-19-Naïve Hospital Personnel
A Santoro, A Capri, D Petrone, F Colavita, S Meschi… - Biomedicines, 2023 - mdpi.com
Background: Vaccine-induced SARS-CoV-2-anti-spike antibody (anti-S/RBD) titers are often
used as a marker of immune protection and to anticipate the risk of breakthrough infections …
used as a marker of immune protection and to anticipate the risk of breakthrough infections …
Third BNT162b2 mRNA SARS-CoV-2 vaccine dose significantly enhances immunogenicity in recipients of allogeneic hematopoietic stem cell transplantation
I Henig, J Isenberg, D Yehudai-Ofir, R Leiba… - Vaccines, 2023 - mdpi.com
COVID-19-related mortality among hematopoietic stem cell transplantation (HSCT)
recipients in the pre-vaccine era ranged between 22 and 33%. The Pfizer/BioNTech …
recipients in the pre-vaccine era ranged between 22 and 33%. The Pfizer/BioNTech …
Complete (humoral and cellular) response to vaccination against COVID-19 in a group of healthcare workers-assessment of factors affecting immunogenicity
E Morgiel, M Szmyrka, M Madej, A Sebastian… - Vaccines, 2022 - mdpi.com
Vaccination is the best way to limit the extent of the COVID pandemic. Knowledge of the
duration of the immune response will allow the planning of a vaccination protocol. This study …
duration of the immune response will allow the planning of a vaccination protocol. This study …
Head-to-head comparison of 5 anti-SARS-CoV-2 assays performance in one hundred COVID-19 vaccinees, over an 8-month course
J Swadźba, T Anyszek, A Panek, A Chojęta… - Diagnostics, 2022 - mdpi.com
The immunoassays used to measure anti-spike SARS-CoV-2 antibodies are widely
available on the market. However, their performance in COVID-19 vaccinees is not yet …
available on the market. However, their performance in COVID-19 vaccinees is not yet …
Humoral and cellular response and associated variables nine months following BNT162b2 vaccination in healthcare workers
N Syrimi, F Sourri, MC Giannakopoulou… - Journal of Clinical …, 2023 - mdpi.com
In this study, we aimed to illustrate the trajectory of humoral and cellular immunity nine
months after primary vaccination with the BNT162b2 mRNA vaccine among 189 healthcare …
months after primary vaccination with the BNT162b2 mRNA vaccine among 189 healthcare …
Would new SARS-CoV-2 variants change the war against COVID-19?
EM Redwan, F Elrashdy, AAA Aljabali… - Epidemiologia, 2022 - mdpi.com
The scientific, private, and industrial sectors use a wide variety of technological platforms
available to achieve protection against SARS-CoV-2 (severe acute respiratory syndrome …
available to achieve protection against SARS-CoV-2 (severe acute respiratory syndrome …